About (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate
(8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate (PubChem CID 139661719) has the molecular formula C19H22N2O4
and a molecular weight of 342.39 g/mol. Its IUPAC name is (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate.
Analyze (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate?
The IUPAC name of (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate (CID 139661719) is (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate.
What is the SMILES notation for (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate?
The canonical SMILES for (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate is O=C(NC1CCCCC1)OC1COc2ccc3[nH]c(=O)ccc3c2C1.
What is the InChIKey of (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate?
The InChIKey is OFDQULPTDFOMPS-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H22N2O4/c22-18-9-6-14-15-10-13(11-24-17(15)8-7-16(14)21-18)25-19(23)20-12-4-2-1-3-5-12/h6-9,12-13H,1-5,10-11H2,(H,20,23)(H,21,22).
What are the key properties of (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate?
(8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate has a molecular weight of 342.39 g/mol, XLogP of 2.89, 2 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (8-oxo-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-2-yl) N-cyclohexylcarbamate is sourced from PubChem (CID 139661719), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).